| PERIOD ENDING | 30-Jun-08 | 31-Mar-08 | 31-Dec-07 | 30-Sep-07 | | Total Revenue | 17,812,726 | 17,846,246 | 17,372,915 | 16,390,450 | | Cost of Revenue | 17,359,390 | 17,287,493 | 16,865,455 | 15,862,020 | | | Gross Profit | 453,336 | 558,753 | 507,460 | 528,430 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 241,722 | 299,168 | 289,940 | 323,244 | | Non Recurring |
-
| (177) | 177 | 2,072 | | Others | 18,157 | 23,040 | 22,353 | 22,094 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 193,457 | 236,722 | 194,990 | 181,020 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,799 | (2,829) | 3,084 | 10,034 | | Earnings Before Interest And Taxes | 200,256 | 233,893 | 198,074 | 191,054 | | Interest Expense | 23,498 | 14,905 | 20,245 | 17,011 | | Income Before Tax | 176,758 | 218,988 | 177,829 | 174,043 | | Income Tax Expense | 66,428 | 85,136 | 68,009 | 61,866 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 110,330 | 133,852 | 109,820 | 112,177 | | | Non-recurring Events | | Discontinued Operations | (218,350) |
-
|
-
| (24,601) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (108,020) | 133,852 | 109,820 | 87,576 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($108,020) | $133,852 | $109,820 | $87,576 |
|
1.49% Nasdaq 
0.27%
Income Statement
